HRMY
USDHarmony Biosciences Holdings Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$29.250
Máximo
$30.890
Mínimo
$27.660
Volumen
1.44M
Fundamentos de la Empresa
Capitalización de Mercado
1.8B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.82M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
WAKIX® (pitolisant) Franchise Delivers Net Revenue of $239M in Q3 2025 (+29% YoY Growth) Record Increase in Average Number of Patients of Approximately 500 to Achieve 8,100 Average Patients in Q3 2025 Strong Cash
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced preliminary results for Q3 2025, highlighted by the following: WAKIX® (pitolisant) franchise delivered net revenue of approximately $239M in Q3
Acciones Relacionadas
NIE
Virtus Equity & Convertible Income Fund Common Shares of Beneficial Interest
KIM
Kimco Realty Corporation (HC)
PED
Pedevco Corp.
GEGGL
Great Elm Group Inc. 7.25% Notes due 2027
PIRS
Pieris Pharmaceuticals Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.